Castle Biosciences, Inc. (NASDAQ:CSTL) Q1 2026 Earnings Call Transcript May 6, 2026
Castle Biosciences, Inc. reports earnings inline with expectations. Reported EPS is $-0.49 EPS, expectations were $-0.49.
Operator: Good afternoon, and welcome to Castle Biosciences, Inc. first quarter 2026 conference call. As a reminder, today’s call is being recorded. We will begin today’s call with opening remarks and introductions, followed by a question-and-answer session. I would like to turn the call...
